Overview

A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer

Status:
Completed
Trial end date:
2016-08-08
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of ASP3550 to goserelin acetate in patients with prostate cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Goserelin